Clinical
trials show the Ayurvedic hair growth serum grows over 11,000 new hair strands
in 90 days while improving hair density and root strength.
MUMBAI,
India, May 18, 2026 : Indulekha has announced the successful
completion of its second large clinical study on the Indulekha Bringha Hair
Growth Serum, further strengthening its position as the most clinically
validated hair growth serum in India.
Key
findings from the latest trials, conducted in 2025 following an earlier study
in 2024:
- 11,000 new hair strands grown in 90 days validated through a rigorous scientific study.
- Grows 2x more hair than serums containing 3% Redensyl
- 74% improvement in the Anagen-to-Telogen
(A:T) ratio establishing the products ability to
restore healthier hair growth cycle.
The
studies were conducted through registered Clinical Research Organisations under
the supervision of dermatologists and Ayurvedic practitioners.
Our
approach has always been to combine authentic Ayurvedic formulations with
rigorous clinical validation. By conducting two independent clinical trials
across two years, we aim to give consumers complete transparency and confidence
in the product’s efficacy and its ability to deliver real, measurable results,”
said Sairam Subramanian, VP, Haircare, Unilever.
The
findings indicate that the formulation supports the natural hair growth cycle
by delivering results at a follicular level. It observed that 97% agreed that
the serum increases thickness and visibly improves hair volume.
The
hair growth market, particularly the scalp serum category, has become
increasingly cluttered with several brands offering similar 3% Redensyl-based
formulations. In the interest of the consumers we serve, it was therefore
essential for us to rigorously evaluate the efficacy of 3% Redensyl through a
comparative clinical study against Indulekha Hair Growth Serum, ensuring a more
robust, credible, and science-backed assessment of performance.
The
dual studies were conducted during 2024 and 2025 on participants aged between
20 and 45 years, including both men and women experiencing early and moderate
hair thinning. The trials evaluated multiple parameters associated with hair
growth and scalp health, including new hair growth, hair shedding, follicle
strength, and scalp barrier function.
Participants
in the study also reported strong visible outcomes:
- 100% observed thicker-looking hair
- 97% reported a noticeable reduction in
hair fall
- 97% experienced improvement in hair
density
The
findings from the 2024 clinical trial have already been published, while the
2025 trial results have been submitted for publication in the International
Journal of Research in Dermatology.
Indulekha’s
efforts reflect a broader effort to bridge traditional Ayurvedic knowledge with
modern dermatological science. All clinical studies are conducted on Indian
participants with real hair fall conditions, ensuring the results are relevant
to Indian scalp characteristics and hair density patterns. With multiple
clinical trials conducted across its portfolio to date, Indulekha continues to
invest in scientific validation of Ayurvedic formulations.
About
Indulekha
Indulekha
is a heritage Ayurvedic brand known for its science-backed expert scalp care
solutions that blend time-tested Ayurvedic wisdom with modern science. The
brand’s iconic Bringha Hair Oil is one of India’s most trusted solutions for
hair growth and Bringha Hair Serum is a natural progression in its promise of
authentic, efficacy driven & clinically proven Ayurveda.
Media
Contact:
Aaditya Navale
Senior Account Executive
Adfactors PR
Aaditya.navale@adfactorspr.com |
8108109839
Nishika Shah
Account Executive
Adfactors PR
nishika.shah@adfactorspr.com
| 8758107815